The Serum Institute Of India
- All
- News
- Videos
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
Billionaire Cyrus Poonawalla Suffers Cardiac Arrest, Stable After Angioplasty
Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
